Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Published 5 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera Therapeutics, the FDA begins agency-wide deployment of new agentic AI tools, and a new report suggests Richard Pazdur is stepping down as director of CDER.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us